These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16278682)

  • 1. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.
    Grandinetti KB; Spengler BA; Biedler JL; Ross RA
    Oncogene; 2006 Feb; 25(5):706-12. PubMed ID: 16278682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts.
    Lazarova DL; Spengler BA; Biedler JL; Ross RA
    Oncogene; 1999 Apr; 18(17):2703-10. PubMed ID: 10348344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
    Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
    Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
    Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
    Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
    Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
    Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
    Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
    Lutz W; Schwab M
    Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
    Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
    Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
    Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
    Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
    Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines.
    Sekido Y; Bader SA; Carbone DP; Johnson BE; Minna JD
    Cancer Res; 1994 Sep; 54(18):4988-92. PubMed ID: 8069866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
    Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.
    Corvi R; Savelyeva L; Schwab M
    Cancer Res; 1995 Aug; 55(16):3471-4. PubMed ID: 7627947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
    Ibson JM; Rabbitts PH
    Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of N-myc as a prognostic marker for patients with neuroblastoma.
    Schwab M
    Semin Cancer Biol; 1993 Feb; 4(1):13-8. PubMed ID: 8448374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA.
    Amler LC; Schwab M
    Oncogene; 1992 Apr; 7(4):807-9. PubMed ID: 1565478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods].
    Melegh Z; Bálint I; Nagy K; Magyarosy E; Galántai I; Szentirmay Z
    Magy Onkol; 2002; 46(1):43-8. PubMed ID: 12050681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18).
    Hailat N; Strahler J; Melhem R; Zhu XX; Brodeur G; Seeger RC; Reynolds CP; Hanash S
    Oncogene; 1990 Nov; 5(11):1615-8. PubMed ID: 2267130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
    Ball NS; King PH
    Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.